A multicentre, prospective randomized, active-controlled feasibility trial of
volatile-based anaesthesia vs. propofol-based total intravenous anaesthesia to
investigate the impact of anaesthesia on long-term (i.e. 5-years) patient cancer outcomes
in patients undergoing elective major cancer surgery.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04074460.
This study aims to assess the feasibility of conducting a phase IV, multi-centre,
single-blinded, randomized control trial (VAPOR-C (Main)).
Primary aims To measure the ability to recruit eligible patients into the study.
To measure the ability to successfully deliver each of the two anaesthetic techniques
(volatile-based general anaesthesia and propofol-based anaesthesia) according to the
research protocol.
Trial PhasePhase IV
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationPeter MacCallum Cancer Centre
